IL6 and neoplasm: ARS affects signaling pathways and transcription factors associated with tumor growth, including the inhibition of the IL-6-JAK-STAT pathway (91), reduction of NF-κB p65 transcriptional activity (92), activation of p38 MAPK (93), and suppression of the Wnt/β-catenin pathway (94).